Primary Ventures

Primary Ventures is a New York seed firm that has made operational support its central claim, and the firm’s healthcare engagement is best understood as an extension of that broader thesis. The firm backs companies emerging from the New York ecosystem and builds a deep working relationship with each one rather than spreading capital and attention thinly across a large portfolio. Healthcare technology fits the pattern when the company looks more like a software or services platform than a biotech bet.

The thesis at the seed stage is healthcare software and digital health, with an explicit AI focus reflecting the firm’s broader move into AI-native enterprise companies. Portfolio examples include Alma, the mental health practice platform, and Dandelion Health, the clinical data company, both of which sit at the intersection of healthcare workflow and software infrastructure rather than traditional clinical-services categories. Founders building services-heavy care delivery without a real software backbone tend to be a poor fit, as do pure pharma and devices plays.

Checks fall in the one to five million dollar range, deployed at seed, with the firm typically leading or co-leading rounds where it engages. Geography is anchored in New York, and the firm’s strongest leverage is its operational and network density inside that ecosystem. Founders headquartered elsewhere can engage but should understand that the firm’s distinctive value is hardest to deliver outside the New York footprint.

The firm is structured around an active operating-support function in addition to a partnership, with dedicated talent, business development, and marketing resources that engage with portfolio companies between rounds. That structure shapes the engagement and is part of what founders are evaluating when they take a Primary check.

The approach is high-touch and explicit. Founders should expect a partnership that engages on hiring, go-to-market, and broader operational questions on a regular cadence rather than appearing only at board meetings. The firm is unusually transparent about how it works and what it does and does not provide, which makes it easier than usual for founders to figure out whether the fit is right. Process is structured: a clear partnership conversation, references with portfolio founders, and a decision. Follow-on participation in later rounds is common and reflects the firm’s stage focus. For New York healthcare and AI founders who want a seed partner whose operational support function is genuinely staffed and used, rather than a marketing line, the fit is concrete.